Explore how India’s Global Capability Centres are transforming into cyber-resilient powerhouses, powered by AI, automation, and strong government policies fostering secure digital growth.
#GTBharat’s PolicyCast is your window into policy, tax, and regulatory developments. Each episode features expert perspectives on issues that matter to businesses, individuals, and the wider economy.
A government-backed initiative with Grant Thornton Bharat enabled farmers and SHGs to access markets, credit, and digital platforms, creating scalable rural growth and sustainable livelihoods.
India and Japan have evolved their relationship into a strong, strategic partnership focused on shared growth and prosperity. This alliance is built on a foundation of economic collaboration, cultural resonance, spiritual connection, and centuries-old civilisational ties. Together, the two nations have made significant strides in navigating the challenges of globalisation and technological change, further deepening their mutual bond.
In this episode, Rajashree Sarna, Partner, Global People Solutions, decodes the Pradhan Mantri Viksit Bharat Rozgar Yojana (PM-VBRY) — an employment-linked incentive scheme aimed at supporting employers and strengthening India’s workforce.
The Bihar healthcare sector is poised to become a key driver of state GDP growth, employment, and social progress. As Bihar targets a trillion-dollar economy by 2047, healthcare can do far more than treat illness. It can expand productive years, reduce out-of-pocket (OOP) spending, catalyse local manufacturing, and professionalise services across an integrated healthcare economy.
In this episode, Dr. Anand Deshpande, Founder, Chairman, and Managing Director at Persistent Systems, joins Pallavi Joshi Bakhru, Partner and Family Office Services Leader at Grant Thornton Bharat, for a candid conversation on entrepreneurship, leadership and legacy.
The September 2025 edition of the Grant Thornton Bharat Monthly US Tax Bulletin provides a concise summary of recent key developments in federal and state taxes in the US.
Technology and healthcare are converging rapidly. Among the most transformative developments are artificial intelligence (AI), deep learning, generative AI, medical and life science focussed Large Language Models/foundational models and the recent rise of Agentic AI. Together they are changing the entire spectrum of healthcare and life science industry - from preventive care to mental health support to drug discovery to imaging and diagnostics to robotics powered surgery.
Stablecoin adoption is rising fast in India despite lack of regulation. As RBI advances its CBDC plans, users face risks from trust, pegs, and issuer failure amid growing remittance use.
Explore how subscription-based businesses use data and analytics to enhance revenue recognition, reduce leakage, comply with standards, and drive scalable, sustainable growth.
India is preparing to launch a Carbon Capture, Utilisation and Storage (CCUS) Mission, a move that can reshape its industrial decarbonisation strategy. If executed well, it can unlock private investments & carbon credit trading besides creating jobs, write Amit Kumar and Pradeep Singhvi.
Future-ready workforce 2.0: C-suite strategies for thriving in a shifting world
India’s food and beverage (F&B) industry is entering a defining phase. While metros have long dominated the sector, the real momentum lies outside the big cities. The F&B industry beyond metros is no longer a distant possibility—it’s a fast-unfolding reality. Tier-II and Tier-III cities are becoming vibrant consumption hubs where aspirations, affordability, and accessibility combine to reshape how India eats, dines, and spends.
India has taken one of the biggest steps in its tax journey since GST was first launched in 2017. On September 3, the GST Council announced what many are calling “GST 2.0”-a simplified tax system with fewer slabs, clearer rules, and new compliance measures. These reforms will come into effect on September 22.
GST overhaul cuts tax on medicines & devices, making healthcare affordable. Pharma and medtech must realign pricing, supply chains, and innovation to drive access and growth.